Skip to main content

Site notifications

VERASEAL (Grifols Australia Pty Ltd)

Product name
VERASEAL
Date registered
Evaluation commenced
Decision date
Approval time
251 (255 working days)
Active ingredients
human fibrinogen; human thrombin
Registration type
NCE/NBE
Indication

VERASEAL (solutions for sealant) is used as supportive treatment in adults where standard surgical techniques are insufficient, for improvement of hemostasis.